after intensive therapy of group A, B, and AB haemophiliacs with factor VIII preparations containing variable quantities of anti-A and anti-B.'-4 In order to assess the clinical significance of anti-A and anti-B levels in various factor VIII preparations it was suggested that assay of these antibodies should be carried out on batches produced at Blood Products Laboratory, Elstree and the Plasma Fractionation Laboratory, Oxford (Maycock, personal communication). Estimations of anti-A and anti-B are usually performed by manual titration, a technique liable to exhibit poor reproducibility between operators. Since the AutoAnalyzer has proved successful for the assay of anti-Rh (D) and found to be reliable in the estimation of the strength of the ABH antigens5-7 it was decided to adapt the continuous flow principle to the assay of anti-A and anti-B. An assessment of the method and its use for the quantitation of anti-A and anti-B in factor VIII preparations of intermediate specific activity is described in this paper.
Material and methods

APPARATUS
The AutoAnalyzer manifold was based on that described by Rosenfield and Haber,8 with modifications incorporated by Gunson et al.9 In addition, a horizontal coil giving a 10-minute delay was added immediately before the entry of the rouleaux dispersal agent. This coil and, as recommended by Gunson et 
METHOD OF ASSAY
Dilutions of the serum standard, bromelised test red cells, PVP, and air were pumped into the manifold. The agglutination reaction was allowed to take place at 370C for 18 minutes followed by 10 minutes at 150C. Rouleaux were dispersed by the addition of 0-5 % BSA in 0-15 M NaCl. After sedimentation, the agglutinates were decanted, and the residual haemoglobin concentration after lysis of the unagglutinated red cells was measured calorimetrically. The dilutions of the standard were chosen so that there was a linear relationship between the antibody concentration and the response measured as A OD, ie, OD of the base-line minus that of the peak height. Figure 1 illustrates a typical standard curve for anti-A assay which is sigmoid in shape, giving a linear relationship between 0-2 and 0 5 unit anti-A. This corresponded to a range of 10 A further experiment revealed that the neutralisation predominantly affected the IgM component of anti-A (and anti-B). The pooled factor VIII standard and the serum standard, however, behaved in a manner similar to a serum containing only IgG anti-A (and anti-B). On this basis, therefore, it was decided to retain AB serum in the red cell suspending medium.
Use ofserum standard It is usual practice to employ the same base material in the standard as that of the test in order that the reactions of the two are comparable. The use of a pooled serum standard, however, has the advantage that a single standard can be used for the assay of anti-A and anti-B in serum and factor VIII preparations and possibly other preparations, for example, factor IX. In order to investigate the feasibility of this proposal, the anti-A levels in 33 factor VIII preparations were determined using both the serum and factor VIII standards. Figure 3 illustrates Since the estimated variance for each set of observations was proportional to the mean for that set, and since the samples studied varied greatly in anti-A/ anti-B content (Table 1) , the analysis was performed on the logs of estimate rather than on the estimates themselves. The standard deviations quoted below are the log standard deviation for each type expressed in anti-log form as a percentage. The findings may be summarised as follows: Anti-A, within day standard deviation ± 5-4% between day standard deviation ± 5 0 % One limitation of the method described above is the potential underestimation of the concentrates of anti-A and/or anti-B in preparations containing principally IgM antibody. In our hands, the search for an acceptable alternative to AB serum in the test red cell suspending medium was not successful. However, the serum and factor VIII standards behaved in a manner similar to a serum containing only IgG anti-A. Factor VIII concentrates are prepared from large pools of plasma and contain principally IgG antibody (unpublished observations), and the use of AB serum in the test red cell suspending medium is, therefore, unlikely to lead to gross underestimation of the antibody concentration. The method reported was devised for the assay of anti-A and anti-B in factor VIII preparations but it can be applied successfully to the assay of those antibodies in serum samples. Results of the investigations into both these aspects will be the subject of a further communication. 
